Pinatuzumab vedotin (INN; development codes DCDT2980S and FCU2703) is a monoclonal antibody designed for the treatment of B-cell malignancies.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.